What is NDC 71205-145?

71205-145 is the product NDC for Ezetimibe, Ezetimibe 10 mg/1 tablet, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.

Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ezetimibe?

40 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ezetimibe NDC 71205-145 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-145Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0145Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-145-30	7120501453071205014530	30 TABLET in 1 BOTTLE (71205-145-30)Marketed from Nov 1, 2018
71205-145-60	7120501456071205014560	60 TABLET in 1 BOTTLE (71205-145-60)Marketed from Nov 1, 2018
71205-145-90	7120501459071205014590	90 TABLET in 1 BOTTLE (71205-145-90)Marketed from Nov 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ezetimibe
Generic name (nonproprietary): ezetimibe
Active ingredients: Ezetimibe — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LPNDC labeler code 71205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203931
Marketing start: Jun 12, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Cholesterol Absorption (Physiologic effect)
Identifiers: Product ID 71205-145_4d2909bd-31fd-4ddc-99b5-2fc99b35f5d4SPL ID 4d2909bd-31fd-4ddc-99b5-2fc99b35f5d4SPL set ID 5cbd9bce-e02d-440f-95d5-4eb958d2f4f3RxCUI 349556UNII EOR26LQQ24
Pharmacologic class: Dietary Cholesterol Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205014530 followed by a unit qualifier and the quantity

Package 71205-0145-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2019.

Indications (excerpt from the label)

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. Ezetimibe tablet is an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet to: 5. Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin) ( 1.1…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71205-145

What is NDC 71205-145?: 71205-145 is the product NDC for Ezetimibe, Ezetimibe 10 mg/1 tablet, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ezetimibe.
What is the active ingredient?: Ezetimibe.
Who is the labeler?: Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ezetimibe?: 40 other product NDCs are listed under this name. See all Ezetimibe NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ezetimibe NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ezetimibe	Ezetimibe 10 mg/1	TabletOral	Safecor Health, LLC	48433-161	48433-0161-03
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-373	33342-0373-0733342-0373-1033342-0373-15
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-787	10135-0787-0510135-0787-3010135-0787-90
ezetimibe	Ezetimibe 10 mg/1	TabletOral	Quallent Pharmaceuticals Health LLC	82009-024	82009-0024-05
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-628	31722-0628-0131722-0628-0531722-0628-10+4 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7689	50090-7689-00
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7690	50090-7690-0050090-7690-01
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-3092	71335-3092-0171335-3092-0271335-3092-03+2 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Orient Pharma Co., Ltd.	76333-170	76333-0170-1276333-0170-1376333-0170-14+1 more
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	A-S Medication Solutions	50090-7338	50090-7338-00

All 41 Ezetimibe NDCs

Other NDCs under ANDA 203931

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203931
Product	Strength	Form · route	Labeler	Product NDC
Ezetimibe	Ezetimibe 10 mg/1	TabletOral	Bryant Ranch Prepack	63629-7413